13F-HR: CVS Health Discloses Q3 2025 Equity Holdings

CVS Health Corp. filed its Form 13F-HR, revealing over $102 million in equity holdings as of September 30, 2025.

Summary

• CVS Health Corp. reported its institutional investment holdings for the quarter ended September 30, 2025.
• The total market value of the disclosed holdings was $102,889,417.
• The report listed 3 distinct equity positions.
• Key holdings included 153,891 shares of SPDR S&P 500 ETF TRUST valued at $102,519,106.
• Other holdings included 2,683 shares of PRUDENTIAL FINANCIAL INC COM valued at $278,334.
• The company also held 32,273 shares of HEALTH CATALYST INC COM valued at $91,977.

Sentiment

Score: 5

Explanation: This is a routine compliance filing disclosing equity holdings, providing factual information without indicating positive or negative operational performance or strategic shifts for CVS Health Corp.

Positives

• The filing demonstrates compliance with SEC regulations for institutional investment managers.

Negatives

• This routine disclosure of past holdings does not inherently contain negative information regarding CVS Health Corp.'s operational performance or strategic outlook.

Risks

• The filing itself does not detail specific operational or strategic risks for CVS Health Corp. It is a disclosure of investment holdings, which inherently carry market risk.

Future Outlook

This filing is a historical disclosure of equity holdings and does not contain any forward-looking statements or guidance from CVS Health Corp.

Industry Context

This Form 13F-HR filing is a standard regulatory disclosure for institutional investment managers, including large corporations like CVS Health Corp. It provides transparency into a portion of the company's investment portfolio, which is a common practice for treasury management or pension fund oversight. The disclosed holdings reflect investment decisions made by the company's internal investment management function.

Comparison to Industry Standards

• The act of filing a Form 13F-HR is a standard compliance requirement for institutional investment managers with over $100 million in qualifying assets, aligning with industry regulatory benchmarks.
• The portfolio composition, primarily featuring a large S&P 500 ETF position, suggests a strategy focused on broad market exposure, which is a common approach for corporate treasury or pension investments seeking diversified returns rather than active stock picking.

Stakeholder Impact

• Shareholders gain transparency into a portion of CVS Health Corp.'s investment portfolio, offering insight into how the company manages some of its capital.

Key Dates

Keywords

CVS Health, 13F, equity holdings, institutional investment, portfolio disclosure, SPDR S&P 500 ETF, Prudential Financial, Health Catalyst, SEC filing